Novel CD123 polyaptamer hydrogel edited by Cas9/sgRNA for AML-targeted therapy

CD123 targeting molecules have been widely applied in acute myelocytic leukemia (AML) therapeutics. Although antibodies have been more widely used as targeting molecules, aptamer have unique advantages for CD123 targeting therapy. In this study, we constructed an aptamer hydrogel termed as SSFH whic...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Drug Deliv
Главные авторы: Wu, Haibin, Zhang, Liyu, Zhu, Zeen, Ding, Chenxi, Chen, Shengquan, Liu, Ruiping, Fan, Huafeng, Chen, Yang, Li, Hui
Формат: Artigo
Язык:Inglês
Опубликовано: Taylor & Francis 2021
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8205012/
https://ncbi.nlm.nih.gov/pubmed/34121564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2021.1934191
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы